Demir, B.Kaplan, A.Capali, V.Sarpun, I. . H.Aydin, A.Tel, E.2020-06-252020-06-252015closedAccess0932-3902https://doi.org/10.3139/124.110477https://hdl.handle.net/20.500.12587/6210SARPUN, Ismail Hakki/0000-0002-9788-699XIn this study, production cross-section calculations of P-32, Sn-117, Sm-153 and Re-186,Re-188 radionuclides used in bone pain palliation treatment produced by Si-30(d,gamma)P-32, Sn-118(gamma,n)Sn-117, Sn-116(n,gamma)Sn-117, Nd-150(alpha,n)Sm-153, Sm-154(n,2n)Sm-153, Sm-152 (n,gamma)Sm-153, W-186(d,2n)Re-186, Re-187(gamma,n)Re-186, Re-185(n,gamma)Re-186 and Re-187(n,gamma)Re-188 reactions have been investigated in the different incident energy range of 0.003-34 MeV. Two-component exciton and generalised superfluid models of the TALYS 1.6 and exciton and generalised superfluid models of the EMPIRE 3.1 computer codes have been used to pre-equilibrium (PEQ) reaction calculations. The calculated production cross-section results have been compared with available experimental results existing in the experimental nuclear reaction database (EXFOR). Except the Sn-118(gamma,n)Sn-117, Nd-150 (alpha,n)Sm-153 and Re-185(n,gamma)Re-186 reactions, the two-component exciton model calculations of TALYS 1.6 code exhibit generally good agreement with the experimental measurements for all reactions used in this present study.eninfo:eu-repo/semantics/closedAccessArticle801586510.3139/124.1104772-s2.0-84928946802Q3WOS:000351750800008Q4